Filing Details
- Accession Number:
- 0001209191-20-008997
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-12 19:03:46
- Reporting Period:
- 2020-02-10
- Accepted Time:
- 2020-02-12 19:03:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1510487 | Principia Biopharma Inc. | PRNB | Pharmaceutical Preparations (2834) | 263487603 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1751719 | David Goldstein | C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-10 | 6,000 | $3.00 | 36,968 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-10 | 800 | $69.53 | 36,168 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-10 | 5,200 | $71.11 | 30,968 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-02-10 | 6,000 | $0.00 | 6,000 | $3.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,447 | 2023-10-23 | No | 4 | M | Direct |
Footnotes
- Includes 1,149 shares acquired under the Employment Stock Purchase Plan on November 15, 2019.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $69.09 to $70.025 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $70.77 to $71.28 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- The stock option is fully vested and immediately exercisable.
Billionaire Hedge Funds
